Inwood Diagnostic & Treatment New York City, NY - 10040

Inwood Diagnostic & Treatment is categorized under Medical Labs in New York City, NY and active since 2009.

Inwood Diagnostic & Treatment was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Andres M Pereira at the company’s single location by writing to 47 Sickles St Office 1a, New York City, New York NY 10040 or by phoning (212) 567-6200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Inwood Diagnostic & Treatment
Contact Person: Andres M Pereira
Address: 47 Sickles St Office 1a, New York City, New York 10040
Phone Number: (212) 567-6200
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 6211110
Share This Business:

Inwood Diagnostic & Treatment was started in 2009 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Andres M Pereira for inquiries that concern Inwood Diagnostic & Treatment by calling the company number (212) 567-6200, as your correspondence is most welcome. Additionally, the physical location of the single location of Inwood Diagnostic & Treatment can be found at the coordinates 40.861452,-73.927843 as well as the street address 47 Sickles St Office 1a in New York City, New York 10040.

For its online presence, you may visit Inwood Diagnostic & Treatment’s website at and engage with its social media outlets through on Twitter and on Facebook.